An Atorvastatin intermediate. Atorvastatin is a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
References
PubChem Literature
From Data Sources
• Winters, R., et al.: J. Med. Chem., 36, 1735 (1993)
• Hagmann, W., et al.: Bioorg. Med. Chem. Lett., 10, 1975 (1993)